Lophius Biosciences is a young biotechnology company developing innovative products for the diagnosis of acute infectious and autoimmune diseases. The company is also offering custom-made services in the area of cell based bioactivity and quality tests for pharmaceutical agents. The core competencies of Lophius Biosciences are in the area of Immunology and T-cell diagnostics.
Funding Rounds (5) - $12MUpdate
|Jul 27, 2016||lophius.com - July 26, 2016 – Lophius Biosciences Closed Financing Round of €4.25 Million to Expand Diagnostic Developments into Tuberculosis and to Strengthen Marketing Activities|
|May 8, 2014||b3cnewswire.com - Lophius Biosciences Secures EUR 2,0 Million Financing and Announces Leadership Changes|
|Jul 19, 2011||FinSMEs - FinSMEs|
|Jul 6, 2010||lophius.de - Lophius Biosciences raises 1970000 in venture round|
Regensburg, Bayern D-93053